Dr. Armen Parsyan
Assistant Professor, Dept. of Surgery, Oncology and Anatomy and Cell Biology
Training
Dr. Armen Parsyan, MD, PhD, DSc, MPH, FRCSC, FACS is a Canadian and American board-certified general surgeon with a subspecialty training in breast surgical oncology. He has been trained in world leading academic institutions, such as the University of Cambridge (PhD), Harvard, Boston (MPH), McGill and Toronto Universities. He has completed postdoctoral research fellowships in the cancer research laboratories of Order of Canada level scientists, such as Professors N. Sonenberg (McGill University) and TW Mak (Princess Margaret Cancer Centre, Toronto).
Achievements
He is a recipient of various national and international awards and grants from the USA, UK, Canada and Ireland. Armen is published in highly-ranked journals such as Nature Reviews Molecular Cell Biology, Science, Cancer Cell, PNAS and others. He chief-edited and published a book by Springer International on fundamental mechanisms of cancer development and progression and is an author of numerous book chapters, abstracts and presentations. He also served as a reviewer for major granting agencies, such as CIHR. Armen is a member of various research, ethics, student and other committees at Western.
Lead Principal Investigator
Dr. Parsyan’s laboratory is located at the Verspeeten Family Cancer Centre in London, ON. Dr. Parsyan’s primary interest is in translational breast cancer research. He uses novel patient-derived models and cutting-edge technologies such as spatial omics, CRISPR-Cas9 and others to study novel drugs’ mechanisms of resistance and sensitivity to novel and existing chemotherapeutic agents and radiotherapy; mechanisms of breast cancer progression and metastases; and the role of the immune system in breast cancer.
Dr. Parsyan's years of advanced clinical and research education and experience is combined with a great passion to fight cancer as a surgeon and a scientist to improve outcomes and alleviate suffering of cancer patients and their loved ones.
(Watch an interview with Breast Cancer Canada in our news section)
